Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Hanson Wade to hold a virtual summit » 09:10
10/27/21
10/27
09:10
10/27/21
09:10
PFE

Pfizer

$43.56 /

+0.39 (+0.90%)

, JNJ

Johnson & Johnson

$165.77 /

+1.66 (+1.01%)

, AMGN

Amgen

$208.61 /

+1.09 (+0.53%)

, GSK

GlaxoSmithKline

$40.18 /

+0.375 (+0.94%)

, BMY

Bristol-Myers

$58.24 /

+0.47 (+0.81%)

, AZN

AstraZeneca

$62.29 /

+0.54 (+0.87%)

, LLY

Eli Lilly

$248.43 /

+3.26 (+1.33%)

, SNY

Sanofi

$49.98 /

+0.125 (+0.25%)

, BAYRY

Bayer

$14.20 /

+0.04 (+0.28%)

, KYMR

Kymera Therapeutics

$56.41 /

+1.19 (+2.16%)

, ARVN

Arvinas

$85.13 /

+0.29 (+0.34%)

, CCCC

C4 Therapeutics

$44.85 /

+0.65 (+1.47%)

, GLUE

Monte Rosa Therapeutics

$25.33 /

+2.91 (+12.98%)

, NRIX

Nurix Therapeutics

$28.77 /

+0.58 (+2.06%)

, FHTX

Foghorn Therapeutics

$12.70 /

+0.235 (+1.89%)

, NVS

Novartis

$84.84 /

+1.49 (+1.79%)

4th Targeted Protein…

4th Targeted Protein Degradation Virtual Summit to be held on October 26-29.Webcast Link

ShowHide Related Items >><<
SNY Sanofi
$49.98 /

+0.125 (+0.25%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

NRIX Nurix Therapeutics
$28.77 /

+0.58 (+2.06%)

LLY Eli Lilly
$248.43 /

+3.26 (+1.33%)

KYMR Kymera Therapeutics
$56.41 /

+1.19 (+2.16%)

JNJ Johnson & Johnson
$165.77 /

+1.66 (+1.01%)

GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

GLUE Monte Rosa Therapeutics
$25.33 /

+2.91 (+12.98%)

FHTX Foghorn Therapeutics
$12.70 /

+0.235 (+1.89%)

CCCC C4 Therapeutics
$44.85 /

+0.65 (+1.47%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

ARVN Arvinas
$85.13 /

+0.29 (+0.34%)

AMGN Amgen
$208.61 /

+1.09 (+0.53%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
JNJ Johnson & Johnson
$165.77 /

+1.66 (+1.01%)

10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
10/20/21 Baird
Intuitive Surgical price target raised to $370 from $350 at Baird
10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
10/04/21 Piper Sandler
Xencor price target raised to $75 from $63 at Piper Sandler
AMGN Amgen
$208.61 /

+1.09 (+0.53%)

10/04/21 Piper Sandler
Amgen's AMG 451 looks competitive with Dupixent, says Piper Sandler
09/23/21 Daiwa
Amgen downgraded to Neutral from Outperform at Daiwa
09/22/21 Stifel
Mirati Therapeutics initiated with a Buy at Stifel
09/21/21 Oppenheimer
Mirati Therapeutics price target raised to $175 from $160 at Oppenheimer
GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

10/18/21 Berenberg
GlaxoSmithKline price target lowered to 1,540 GBp from 1,625 GBp at Berenberg
10/07/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,555 GBp at Morgan Stanley
10/07/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,555 GBp at Morgan Stanley
10/04/21 Alliance Global Partners
Achieve Life Sciences initiated with a Buy at Alliance Global Partners
BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
10/25/21 SVB Leerink
Potential Bristol takeover of Aurinia makes strategic sense, says SVB Leerink
10/25/21 Citi
Bristol-Myers report of Aurinia approach 'looks credible,' says Citi
10/12/21 Morgan Stanley
Bristol-Myers price target lowered to $66 from $71 at Morgan Stanley
AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

09:01 Today SVB Leerink
Seagen price target raised to $200 from $190 at SVB Leerink
10/19/21 UBS
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS
10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
LLY Eli Lilly
$248.43 /

+3.26 (+1.33%)

06:39 Today Mizuho
Eli Lilly price target lowered to $272 from $279 at Mizuho
10/11/21
Fly Intel: Top five analyst upgrades
10/11/21 Berenberg
Eli Lilly upgraded to Buy from Hold at Berenberg
09/30/21 RBC Capital
Prothena price target raised to $82 from $59 at RBC Capital
SNY Sanofi
$49.98 /

+0.125 (+0.25%)

10/25/21 H.C. Wainwright
Regeneron trial data reinforce bullish outlook on Dupixent, says H.C. Wainwright
10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

10/21/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
08/09/21 Berenberg
Bayer price target lowered to EUR 60 from EUR 74 at Berenberg
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
KYMR Kymera Therapeutics
$56.41 /

+1.19 (+2.16%)

10/13/21 Brookline
Kymera Therapeutics initiated with Buy, $80 target at Brookline
10/12/21 Brookline
Kymera Therapeutics initiated with a Buy at Brookline
09/30/21 B. Riley
Kymera Therapeutics initiated with Neutral on valuation at B. Riley
09/30/21 B. Riley
Kymera Therapeutics initiated with a Neutral at B. Riley
ARVN Arvinas
$85.13 /

+0.29 (+0.34%)

10/20/21 Stifel
Success of Radius' elacestrant lowers risk for Arvinas' ARV-471, says Stifel
10/14/21 SVB Leerink
Arvinas initiated with an Outperform at SVB Leerink
09/29/21 Stifel
Arvinas initiated with a Buy at Stifel
09/09/21 BofA
Arvinas initiated with a Buy at BofA
CCCC C4 Therapeutics
$44.85 /

+0.65 (+1.47%)

10/14/21 SVB Leerink
C4 Therapeutics initiated with a Market Perform at SVB Leerink
09/29/21 Stifel
C4 Therapeutics initiated with a Hold at Stifel
06/24/21 Brookline
C4 Therapeutics initiated with a Buy at Brookline
06/22/21 BMO Capital
C4 Therapeutics price target lowered to $53 from $55 at BMO Capital
GLUE Monte Rosa Therapeutics
$25.33 /

+2.91 (+12.98%)

10/14/21 SVB Leerink
Monte Rosa Therapeutics initiated with a Market Perform at SVB Leerink
07/19/21 JPMorgan
Monte Rosa Therapeutics initiated with an Overweight at JPMorgan
07/19/21 Guggenheim
Monte Rosa Therapeutics initiated with a Buy at Guggenheim
07/19/21 Piper Sandler
Monte Rosa Therapeutics initiated with an Overweight at Piper Sandler
NRIX Nurix Therapeutics
$28.77 /

+0.58 (+2.06%)

10/14/21 SVB Leerink
Nurix Therapeutics initiated with an Outperform at SVB Leerink
06/03/21 Baird
Nurix Therapeutics transferred with Outperform at Baird
04/30/21
Fly Intel: Top five analyst initiations
04/30/21 RBC Capital
Nurix Therapeutics initiated with an Outperform at RBC Capital
FHTX Foghorn Therapeutics
$12.70 /

+0.235 (+1.89%)

11/17/20 Morgan Stanley
Foghorn Therapeutics initiated with an Overweight at Morgan Stanley
11/17/20 Wedbush
Wedbush bullish on Foghorn Therapeutics, initiates with an Outperform
11/17/20 Wedbush
Foghorn Therapeutics initiated with an Outperform at Wedbush
11/17/20 Cowen
Foghorn Therapeutics initiated with an Outperform at Cowen
NVS Novartis
$84.84 /

+1.49 (+1.79%)

10/12/21 Berenberg
Novartis price target lowered to CHF 88 from CHF 96 at Berenberg
10/08/21 UBS
Novartis price target lowered to CHF 92 from CHF 95 at UBS
09/29/21 Stifel
Blueprint Medicines rersumed with a Hold at Stifel
09/20/21 Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
SNY Sanofi
$49.98 /

+0.125 (+0.25%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

NRIX Nurix Therapeutics
$28.77 /

+0.58 (+2.06%)

LLY Eli Lilly
$248.43 /

+3.26 (+1.33%)

KYMR Kymera Therapeutics
$56.41 /

+1.19 (+2.16%)

JNJ Johnson & Johnson
$165.77 /

+1.66 (+1.01%)

GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

GLUE Monte Rosa Therapeutics
$25.33 /

+2.91 (+12.98%)

CCCC C4 Therapeutics
$44.85 /

+0.65 (+1.47%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

ARVN Arvinas
$85.13 /

+0.29 (+0.34%)

AMGN Amgen
$208.61 /

+1.09 (+0.53%)

  • 01
    Jul
  • 24
    Jun
  • 17
    Jun
  • 05
    Mar
  • 16
    Dec
SNY Sanofi
$49.98 /

+0.125 (+0.25%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

LLY Eli Lilly
$248.43 /

+3.26 (+1.33%)

JNJ Johnson & Johnson
$165.77 /

+1.66 (+1.01%)

GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

SNY Sanofi
$49.98 /

+0.125 (+0.25%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

LLY Eli Lilly
$248.43 /

+3.26 (+1.33%)

KYMR Kymera Therapeutics
$56.41 /

+1.19 (+2.16%)

JNJ Johnson & Johnson
$165.77 /

+1.66 (+1.01%)

GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

GLUE Monte Rosa Therapeutics
$25.33 /

+2.91 (+12.98%)

CCCC C4 Therapeutics
$44.85 /

+0.65 (+1.47%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

AMGN Amgen
$208.61 /

+1.09 (+0.53%)

PFE Pfizer
$43.56 /

+0.39 (+0.90%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

LLY Eli Lilly
$248.43 /

+3.26 (+1.33%)

KYMR Kymera Therapeutics
$56.41 /

+1.19 (+2.16%)

JNJ Johnson & Johnson
$165.77 /

+1.66 (+1.01%)

GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

FHTX Foghorn Therapeutics
$12.70 /

+0.235 (+1.89%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

AMGN Amgen
$208.61 /

+1.09 (+0.53%)

Conference/Events
American Society for Radiation Oncology to hold annual meeting » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
ARAY

Accuray

$4.31 /

-0.08 (-1.82%)

, NVS

Novartis

$84.84 /

+1.49 (+1.79%)

, AZN

AstraZeneca

$62.29 /

+0.54 (+0.87%)

, BAYRY

Bayer

$14.20 /

+0.04 (+0.28%)

, BD

Budget Group

/

+

, BIOC

Biocept

$3.76 /

-0.08 (-2.08%)

, BSX

Boston Scientific

$44.32 /

-0.17 (-0.38%)

, BMY

Bristol-Myers

$58.24 /

+0.47 (+0.81%)

, EKTAY

Elekta

$11.58 /

+0.09 (+0.78%)

, GRTX

Galera Therapeutics

$1.88 /

+0.04 (+2.17%)

, DNA

Ginkgo Bioworks

$14.46 /

+0.19 (+1.33%)

, HTHIY

Hitachi

$118.77 /

-0.71 (-0.59%)

, MRK

Merck

$82.23 /

+0.545 (+0.67%)

, MYGN

Myriad Genetics

$30.66 /

-1.81 (-5.57%)

, NBTX

Nanobiotix

$12.35 /

-0.3 (-2.37%)

, NNOX

Nano-X Imaging

$22.54 /

-0.55 (-2.38%)

, NTRA

Natera

$115.95 /

+0.2 (+0.17%)

, NVCR

Novocure

$113.51 /

-5.91 (-4.95%)

, PHG

Philips

$47.69 /

-0.12 (-0.25%)

, REGN

Regeneron

$592.37 /

+16.45 (+2.86%)

, SNY

Sanofi

$49.98 /

+0.125 (+0.25%)

, SGEN

Seagen

$177.70 /

+2.29 (+1.31%)

, SMMNY

Siemens Healthineers

$34.66 /

-0.07 (-0.20%)

, SYK

Stryker

$273.25 /

+0.08 (+0.03%)

, TDY

Teledyne

$437.11 /

-7.89 (-1.77%)

, VRAY

ViewRay

$6.96 /

-0.05 (-0.71%)

, VREX

Varex Imaging

$26.36 /

-0.7 (-2.59%)

63rd Annual ASTRO Meeting…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRAY ViewRay
$6.96 /

-0.05 (-0.71%)

TDY Teledyne
$437.11 /

-7.89 (-1.77%)

SYK Stryker
$273.25 /

+0.08 (+0.03%)

SNY Sanofi
$49.98 /

+0.125 (+0.25%)

SMMNY Siemens Healthineers
$34.66 /

-0.07 (-0.20%)

SGEN Seagen
$177.70 /

+2.29 (+1.31%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

NVCR Novocure
$113.51 /

-5.91 (-4.95%)

NTRA Natera
$115.95 /

+0.2 (+0.17%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

NBTX Nanobiotix
$12.35 /

-0.3 (-2.37%)

MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

HTHIY Hitachi
$118.77 /

-0.71 (-0.59%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

EKTAY Elekta
$11.58 /

+0.09 (+0.78%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BIOC Biocept
$3.76 /

-0.08 (-2.08%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

ARAY Accuray
$4.31 /

-0.08 (-1.82%)

ARAY Accuray
$4.31 /

-0.08 (-1.82%)

10/26/21 Lake Street
Investors should buy Accuray after 'excellent' ASTRO meeting, says Lake Street
01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
NVS Novartis
$84.84 /

+1.49 (+1.79%)

10/12/21 Berenberg
Novartis price target lowered to CHF 88 from CHF 96 at Berenberg
10/08/21 UBS
Novartis price target lowered to CHF 92 from CHF 95 at UBS
09/29/21 Stifel
Blueprint Medicines rersumed with a Hold at Stifel
09/20/21 Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

10/19/21 UBS
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS
10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

10/21/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
08/09/21 Berenberg
Bayer price target lowered to EUR 60 from EUR 74 at Berenberg
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
BD Budget Group
/

+

BIOC Biocept
$3.76 /

-0.08 (-2.08%)

10/08/21 Brookline
Biocept assumed with a Buy at Brookline
BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

10/06/21 Piper Sandler
Boston Scientific acquisition of Baylis looks 'solid,' says Piper Sandler
09/22/21 Piper Sandler
Boston Scientific said unlikely to hit low end of Q3 sales outlook, notes Piper
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
10/25/21 SVB Leerink
Potential Bristol takeover of Aurinia makes strategic sense, says SVB Leerink
10/25/21 Citi
Bristol-Myers report of Aurinia approach 'looks credible,' says Citi
10/12/21 Morgan Stanley
Bristol-Myers price target lowered to $66 from $71 at Morgan Stanley
EKTAY Elekta
$11.58 /

+0.09 (+0.78%)

08/27/21 JPMorgan
Elekta price target raised to SEK 95 from SEK 91 at JPMorgan
06/02/21 JPMorgan
Elekta price target raised to SEK 91 from SEK 82 at JPMorgan
04/27/21 JPMorgan
Elekta price target raised to SEK 82 from SEK 80 at JPMorgan
03/18/21 JPMorgan
Elekta downgraded to Underweight from Neutral at JPMorgan
GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

10/21/21 Citi
Galera Therapeutics price target lowered to $11 from $21 at Citi
10/20/21 H.C. Wainwright
Galera Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/19/21 BofA
Galera double downgraded to Underperform at BofA after ROMAN trial miss
10/19/21 BofA
Galera Therapeutics downgraded to Underperform from Buy at BofA
DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

10/20/21 Raymond James
Raymond James expects more equity-based payments for Ginkgo as milestones met
10/13/21 Raymond James
Ginkgo Bioworks initiated with an Outperform at Raymond James
10/12/21 William Blair
Blair starts Ginkgo at Outperform on 'significant' competitive advantage
10/12/21 William Blair
Ginkgo Bioworks initiated with an Outperform at William Blair
HTHIY Hitachi
$118.77 /

-0.71 (-0.59%)

11/20/20 Goldman Sachs
Hitachi reinstated with a Sell at Goldman Sachs
MRK Merck
$82.23 /

+0.545 (+0.67%)

10/22/21 SVB Leerink
Merck price target raised to $105 from $104 at SVB Leerink
10/19/21 Roth Capital
Enanta drug 'naturally more potent' than Merck's antiviral, says Roth Capital
10/19/21 Evercore ISI
Atea's Phase 2 design disappoints, but drug has not failed, says Evercore ISI
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

10/14/21 Cowen
Myriad Genetics coverage transferred at Cowen
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Myriad Genetics initiated with a Market Perform at Raymond James
06/03/21 Goldman Sachs
Myriad Genetics initiated with a Sell at Goldman Sachs
NBTX Nanobiotix
$12.35 /

-0.3 (-2.37%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

04/19/21 Ladenburg
Ladenburg starts Nano-X Imaging at Buy with $52 price target
04/19/21 Ladenburg
Nano-X Imaging initiated with a Buy at Ladenburg
02/01/21 Cantor Fitzgerald
Cantor Fitzgerald reiterates Overweight on Nano-X Imaging, lowers target to $67
NTRA Natera
$115.95 /

+0.2 (+0.17%)

10/19/21 Canaccord
Natera Prospera Lung launch to continue momentum, says Canaccord
10/14/21 Cowen
Natera coverage transferred at Cowen
08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
08/09/21 Piper Sandler
Natera price target raised to $160 from $155 at Piper Sandler
NVCR Novocure
$113.51 /

-5.91 (-4.95%)

10/25/21 Piper Sandler
Novocure price target lowered to $195 from $235 at Piper Sandler
09/21/21 Piper Sandler
Novocure clinical update should come in next few weeks, says Piper Sandler
07/30/21 Mizuho
Novocure price target lowered to $200 from $229 at Mizuho
PHG Philips
$47.69 /

-0.12 (-0.25%)

10/25/21 Credit Suisse
Philips price target lowered to EUR 42 from EUR 49 at Credit Suisse
10/19/21 JPMorgan
Philips price target lowered to EUR 36.40 from EUR 40.90 at JPMorgan
10/19/21 Deutsche Bank
Philips price target lowered to EUR 42 from EUR 43 at Deutsche Bank
09/10/21 Barclays
Philips price target lowered to EUR 53 from EUR 54 at Barclays
REGN Regeneron
$592.37 /

+16.45 (+2.86%)

10/26/21 SVB Leerink
Regeneron price target raised to $798 from $785 at SVB Leerink
10/25/21 H.C. Wainwright
Regeneron trial data reinforce bullish outlook on Dupixent, says H.C. Wainwright
10/22/21 H.C. Wainwright
Regeneron price target raised to $842 from $831 at H.C. Wainwright
10/14/21 H.C. Wainwright
H.C. Wainwright 'enthusiastic' on Regeneron, sees no barrier for REGEN-COV nod
SNY Sanofi
$49.98 /

+0.125 (+0.25%)

10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
SGEN Seagen
$177.70 /

+2.29 (+1.31%)

10/14/21 BTIG
Seagen assumed with a Neutral at BTIG
09/27/21 RBC Capital
Seagen price target raised to $154 from $148 at RBC Capital
05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
SMMNY Siemens Healthineers
$34.66 /

-0.07 (-0.20%)

10/13/21 UBS
Siemens Healthineers price target raised to EUR 54 from EUR 48 at UBS
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold at Societe Generale
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold from Buy at Societe Generale
09/10/21 Barclays
Siemens Healthineers price target raised to EUR 55 from EUR 49 at Barclays
SYK Stryker
$273.25 /

+0.08 (+0.03%)

09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 SVB Leerink
Stryker price target raised to $300 from $290 at SVB Leerink
TDY Teledyne
$437.11 /

-7.89 (-1.77%)

07/30/21 Cowen
Teledyne price target raised to $525 from $500 at Cowen
06/08/21 Goldman Sachs
Teledyne reinstated with a Neutral at Goldman Sachs
05/25/21 BofA
Teledyne initiated with a Buy at BofA
04/29/21 Needham
Teledyne price target raised to $500 from $416 at Needham
VRAY ViewRay
$6.96 /

-0.05 (-0.71%)

10/19/21 Piper Sandler
ViewRay strength attributed to MIRAGE study recruiting halt, says Piper Sandler
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
06/25/21 Morgan Stanley
ViewRay upgraded to Equal Weight from Underweight at Morgan Stanley
VREX Varex Imaging
$26.36 /

-0.7 (-2.59%)

02/05/21 Oppenheimer
Varex Imaging upgraded to Outperform from Perform at Oppenheimer
VREX Varex Imaging
$26.36 /

-0.7 (-2.59%)

VRAY ViewRay
$6.96 /

-0.05 (-0.71%)

TDY Teledyne
$437.11 /

-7.89 (-1.77%)

SYK Stryker
$273.25 /

+0.08 (+0.03%)

SNY Sanofi
$49.98 /

+0.125 (+0.25%)

SGEN Seagen
$177.70 /

+2.29 (+1.31%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

NVCR Novocure
$113.51 /

-5.91 (-4.95%)

NTRA Natera
$115.95 /

+0.2 (+0.17%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

NBTX Nanobiotix
$12.35 /

-0.3 (-2.37%)

MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BIOC Biocept
$3.76 /

-0.08 (-2.08%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

ARAY Accuray
$4.31 /

-0.08 (-1.82%)

  • 22
    Jul
  • 11
    Feb
  • 22
    Jan
  • 05
    Jan
  • 11
    Dec
SNY Sanofi
$49.98 /

+0.125 (+0.25%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

HTHIY Hitachi
$118.77 /

-0.71 (-0.59%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

VREX Varex Imaging
$26.36 /

-0.7 (-2.59%)

SYK Stryker
$273.25 /

+0.08 (+0.03%)

SNY Sanofi
$49.98 /

+0.125 (+0.25%)

SMMNY Siemens Healthineers
$34.66 /

-0.07 (-0.20%)

SGEN Seagen
$177.70 /

+2.29 (+1.31%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

NVCR Novocure
$113.51 /

-5.91 (-4.95%)

NTRA Natera
$115.95 /

+0.2 (+0.17%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

TDY Teledyne
$437.11 /

-7.89 (-1.77%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

Yesterday
Hot Stocks
J&J says removed from pending Texas litigation with settlement » 12:32
10/26/21
10/26
12:32
10/26/21
12:32
JNJ

Johnson & Johnson

$165.25 /

+1.14 (+0.69%)

Johnson & Johnson…

Johnson & Johnson announced a settlement agreement with Texas and its participating subdivisions resolving their opioid-related claims against the company. With this agreement, J&J is removed from the pending Texas state and subdivision litigation, including two trials scheduled for early 2022. The $297M settlement with Texas is consistent with the terms of the previously announced nationwide opioid settlement agreement, the company said in a statement. The dollar amount to be received by the state is the pro-rated share it would have received under the agreement, which will be deducted from the all-in settlement amount, J&J noted.

ShowHide Related Items >><<
JNJ Johnson & Johnson
$165.25 /

+1.14 (+0.69%)

JNJ Johnson & Johnson
$165.25 /

+1.14 (+0.69%)

10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
10/20/21 Baird
Intuitive Surgical price target raised to $370 from $350 at Baird
10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
10/04/21 Piper Sandler
Xencor price target raised to $75 from $63 at Piper Sandler
JNJ Johnson & Johnson
$165.25 /

+1.14 (+0.69%)

JNJ Johnson & Johnson
$165.25 /

+1.14 (+0.69%)

JNJ Johnson & Johnson
$165.25 /

+1.14 (+0.69%)

JNJ Johnson & Johnson
$165.25 /

+1.14 (+0.69%)

Hot Stocks
Texas announces $290M opioid settlement agreement with J&J » 11:58
10/26/21
10/26
11:58
10/26/21
11:58
JNJ

Johnson & Johnson

$164.50 /

+0.39 (+0.24%)

Texas Attorney General…

Texas Attorney General Ken Paxton announced a $290M statewide opioid settlement agreement with Johnson & Johnson to resolve the state's opioid-related claims. The agreement will largely track the terms of the "Global Prescription Opioid Litigation Settlement Agreement" that was announced July 23, Paxton said in a statement. Reference Link

ShowHide Related Items >><<
JNJ Johnson & Johnson
$164.50 /

+0.39 (+0.24%)

JNJ Johnson & Johnson
$164.50 /

+0.39 (+0.24%)

10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
10/20/21 Baird
Intuitive Surgical price target raised to $370 from $350 at Baird
10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
10/04/21 Piper Sandler
Xencor price target raised to $75 from $63 at Piper Sandler
JNJ Johnson & Johnson
$164.50 /

+0.39 (+0.24%)

JNJ Johnson & Johnson
$164.50 /

+0.39 (+0.24%)

JNJ Johnson & Johnson
$164.50 /

+0.39 (+0.24%)

JNJ Johnson & Johnson
$164.50 /

+0.39 (+0.24%)

Hot Stocks
Protagonist Therapeutics earns $7.5M milestone payment from Janssen Biotech » 07:07
10/26/21
10/26
07:07
10/26/21
07:07
PTGX

Protagonist Therapeutics

$31.94 /

+0.95 (+3.07%)

, JNJ

Johnson & Johnson

$164.15 /

+0.44 (+0.27%)

Protagonist Therapeutics…

Protagonist Therapeutics (PTGX) announced that it will receive a $7.5M milestone payment from Janssen Biotech (JNJ) triggered by the completion of the clinical data collection-related Phase 1 activities for PN-235. This investigational drug candidate is one of the three IL-23 receptor antagonists that are part of Protagonist's collaboration agreement with Janssen, which provides for concurrent development of multiple oral IL-23 receptor antagonists against a broad range of indications.

ShowHide Related Items >><<
PTGX Protagonist Therapeutics
$31.94 /

+0.95 (+3.07%)

JNJ Johnson & Johnson
$164.15 /

+0.44 (+0.27%)

PTGX Protagonist Therapeutics
$31.94 /

+0.95 (+3.07%)

10/13/21 JMP Securities
Protagonist Therapeutics price target raised to $60 from $47 at JMP Securities
10/12/21 JPMorgan
JPMorgan upgrades Protagonist after 'rapid' clinical hold removal
10/12/21 JPMorgan
Protagonist Therapeutics upgraded to Overweight from Neutral at JPMorgan
10/11/21 Jefferies
Protagonist Therapeutics price target raised to $60 from $29 at Jefferies
JNJ Johnson & Johnson
$164.15 /

+0.44 (+0.27%)

10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
10/20/21 Baird
Intuitive Surgical price target raised to $370 from $350 at Baird
10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
10/04/21 Piper Sandler
Xencor price target raised to $75 from $63 at Piper Sandler
PTGX Protagonist Therapeutics
$31.94 /

+0.95 (+3.07%)

JNJ Johnson & Johnson
$164.15 /

+0.44 (+0.27%)

  • 16
    Jun
  • 11
    Dec
JNJ Johnson & Johnson
$164.15 /

+0.44 (+0.27%)

PTGX Protagonist Therapeutics
$31.94 /

+0.95 (+3.07%)

JNJ Johnson & Johnson
$164.15 /

+0.44 (+0.27%)

PTGX Protagonist Therapeutics
$31.94 /

+0.95 (+3.07%)

JNJ Johnson & Johnson
$164.15 /

+0.44 (+0.27%)

Conference/Events
American Society for Radiation Oncology to hold annual meeting » 04:55
10/26/21
10/26
04:55
10/26/21
04:55
ARAY

Accuray

$4.39 /

+0.02 (+0.46%)

, NVS

Novartis

$83.37 /

-1.515 (-1.78%)

, AZN

AstraZeneca

$61.75 /

-0.06 (-0.10%)

, BAYRY

Bayer

$14.16 /

+0.025 (+0.18%)

, BD

Budget Group

/

+

, BIOC

Biocept

$3.84 /

-0.02 (-0.52%)

, BSX

Boston Scientific

$44.49 /

-0.355 (-0.79%)

, BMY

Bristol-Myers

$57.84 /

+0.25 (+0.43%)

, EKTAY

Elekta

$11.49 /

-0.14 (-1.20%)

, GRTX

Galera Therapeutics

$1.84 /

+0.02 (+1.10%)

, DNA

Ginkgo Bioworks

$14.27 /

+1.145 (+8.72%)

, HTHIY

Hitachi

$119.48 /

+1.76 (+1.50%)

, MRK

Merck

$81.68 /

+0.52 (+0.64%)

, MYGN

Myriad Genetics

$32.47 /

+0.03 (+0.09%)

, NBTX

Nanobiotix

$12.35 /

-0.7 (-5.36%)

, NNOX

Nano-X Imaging

$23.08 /

+0.345 (+1.52%)

, NTRA

Natera

$115.78 /

+0.82 (+0.71%)

, NVCR

Novocure

$119.37 /

-1.5 (-1.24%)

, PHG

Philips

$47.81 /

-0.3 (-0.62%)

, REGN

Regeneron

$576.15 /

+3.42 (+0.60%)

, SNY

Sanofi

$49.85 /

+ (+0.00%)

, SGEN

Seagen

$175.45 /

+4.14 (+2.42%)

, SMMNY

Siemens Healthineers

$34.73 /

+0.342 (+0.99%)

, SYK

Stryker

$273.17 /

-2.71 (-0.98%)

, TDY

Teledyne

$444.97 /

-1.14 (-0.26%)

, VRAY

ViewRay

$7.01 /

+0.205 (+3.01%)

, VREX

Varex Imaging

$27.05 /

+0.12 (+0.45%)

63rd Annual ASTRO Meeting…

63rd Annual ASTRO Meeting 2021 will be held in Chicago on October 24-27.Webcast Link

ShowHide Related Items >><<
VRAY ViewRay
$7.01 /

+0.205 (+3.01%)

TDY Teledyne
$444.97 /

-1.14 (-0.26%)

SYK Stryker
$273.17 /

-2.71 (-0.98%)

SNY Sanofi
$49.85 /

+ (+0.00%)

SMMNY Siemens Healthineers
$34.73 /

+0.342 (+0.99%)

SGEN Seagen
$175.45 /

+4.14 (+2.42%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

PHG Philips
$47.81 /

-0.3 (-0.62%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

NVCR Novocure
$119.37 /

-1.5 (-1.24%)

NTRA Natera
$115.78 /

+0.82 (+0.71%)

NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

NBTX Nanobiotix
$12.35 /

-0.7 (-5.36%)

MYGN Myriad Genetics
$32.47 /

+0.03 (+0.09%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

HTHIY Hitachi
$119.48 /

+1.76 (+1.50%)

GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

EKTAY Elekta
$11.49 /

-0.14 (-1.20%)

DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

BIOC Biocept
$3.84 /

-0.02 (-0.52%)

BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

ARAY Accuray
$4.39 /

+0.02 (+0.46%)

ARAY Accuray
$4.39 /

+0.02 (+0.46%)

01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
NVS Novartis
$83.37 /

-1.515 (-1.78%)

10/12/21 Berenberg
Novartis price target lowered to CHF 88 from CHF 96 at Berenberg
10/08/21 UBS
Novartis price target lowered to CHF 92 from CHF 95 at UBS
09/29/21 Stifel
Blueprint Medicines rersumed with a Hold at Stifel
09/20/21 Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

10/19/21 UBS
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS
10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

10/21/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
08/09/21 Berenberg
Bayer price target lowered to EUR 60 from EUR 74 at Berenberg
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
BD Budget Group
/

+

BIOC Biocept
$3.84 /

-0.02 (-0.52%)

10/08/21 Brookline
Biocept assumed with a Buy at Brookline
BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

10/06/21 Piper Sandler
Boston Scientific acquisition of Baylis looks 'solid,' says Piper Sandler
09/22/21 Piper Sandler
Boston Scientific said unlikely to hit low end of Q3 sales outlook, notes Piper
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

10/25/21 SVB Leerink
Potential Bristol takeover of Aurinia makes strategic sense, says SVB Leerink
10/25/21 Citi
Bristol-Myers report of Aurinia approach 'looks credible,' says Citi
10/12/21 Morgan Stanley
Bristol-Myers price target lowered to $66 from $71 at Morgan Stanley
10/08/21 Morgan Stanley
Bristol-Myers' UC trial miss an incremental negative, says Morgan Stanley
EKTAY Elekta
$11.49 /

-0.14 (-1.20%)

08/27/21 JPMorgan
Elekta price target raised to SEK 95 from SEK 91 at JPMorgan
06/02/21 JPMorgan
Elekta price target raised to SEK 91 from SEK 82 at JPMorgan
04/27/21 JPMorgan
Elekta price target raised to SEK 82 from SEK 80 at JPMorgan
03/18/21 JPMorgan
Elekta downgraded to Underweight from Neutral at JPMorgan
GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

10/21/21 Citi
Galera Therapeutics price target lowered to $11 from $21 at Citi
10/20/21 H.C. Wainwright
Galera Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/19/21 BofA
Galera double downgraded to Underperform at BofA after ROMAN trial miss
10/19/21 BofA
Galera Therapeutics downgraded to Underperform from Buy at BofA
DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

10/20/21 Raymond James
Raymond James expects more equity-based payments for Ginkgo as milestones met
10/13/21 Raymond James
Ginkgo Bioworks initiated with an Outperform at Raymond James
10/12/21 William Blair
Blair starts Ginkgo at Outperform on 'significant' competitive advantage
10/12/21 William Blair
Ginkgo Bioworks initiated with an Outperform at William Blair
HTHIY Hitachi
$119.48 /

+1.76 (+1.50%)

11/20/20 Goldman Sachs
Hitachi reinstated with a Sell at Goldman Sachs
MRK Merck
$81.68 /

+0.52 (+0.64%)

10/22/21 SVB Leerink
Merck price target raised to $105 from $104 at SVB Leerink
10/19/21 Roth Capital
Enanta drug 'naturally more potent' than Merck's antiviral, says Roth Capital
10/19/21 Evercore ISI
Atea's Phase 2 design disappoints, but drug has not failed, says Evercore ISI
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
MYGN Myriad Genetics
$32.47 /

+0.03 (+0.09%)

10/14/21 Cowen
Myriad Genetics coverage transferred at Cowen
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Myriad Genetics initiated with a Market Perform at Raymond James
06/03/21 Goldman Sachs
Myriad Genetics initiated with a Sell at Goldman Sachs
NBTX Nanobiotix
$12.35 /

-0.7 (-5.36%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

04/19/21 Ladenburg
Ladenburg starts Nano-X Imaging at Buy with $52 price target
04/19/21 Ladenburg
Nano-X Imaging initiated with a Buy at Ladenburg
02/01/21 Cantor Fitzgerald
Cantor Fitzgerald reiterates Overweight on Nano-X Imaging, lowers target to $67
NTRA Natera
$115.78 /

+0.82 (+0.71%)

10/19/21 Canaccord
Natera Prospera Lung launch to continue momentum, says Canaccord
10/14/21 Cowen
Natera coverage transferred at Cowen
08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
08/09/21 Piper Sandler
Natera price target raised to $160 from $155 at Piper Sandler
NVCR Novocure
$119.37 /

-1.5 (-1.24%)

10/25/21 Piper Sandler
Novocure price target lowered to $195 from $235 at Piper Sandler
09/21/21 Piper Sandler
Novocure clinical update should come in next few weeks, says Piper Sandler
07/30/21 Mizuho
Novocure price target lowered to $200 from $229 at Mizuho
PHG Philips
$47.81 /

-0.3 (-0.62%)

10/25/21 Credit Suisse
Philips price target lowered to EUR 42 from EUR 49 at Credit Suisse
10/19/21 JPMorgan
Philips price target lowered to EUR 36.40 from EUR 40.90 at JPMorgan
10/19/21 Deutsche Bank
Philips price target lowered to EUR 42 from EUR 43 at Deutsche Bank
09/10/21 Barclays
Philips price target lowered to EUR 53 from EUR 54 at Barclays
REGN Regeneron
$576.15 /

+3.42 (+0.60%)

10/25/21 H.C. Wainwright
Regeneron trial data reinforce bullish outlook on Dupixent, says H.C. Wainwright
10/22/21 H.C. Wainwright
Regeneron price target raised to $842 from $831 at H.C. Wainwright
10/14/21 H.C. Wainwright
H.C. Wainwright 'enthusiastic' on Regeneron, sees no barrier for REGEN-COV nod
10/04/21 Piper Sandler
Amgen's AMG 451 looks competitive with Dupixent, says Piper Sandler
SNY Sanofi
$49.85 /

+ (+0.00%)

10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
SGEN Seagen
$175.45 /

+4.14 (+2.42%)

10/14/21 BTIG
Seagen assumed with a Neutral at BTIG
09/27/21 RBC Capital
Seagen price target raised to $154 from $148 at RBC Capital
05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
SMMNY Siemens Healthineers
$34.73 /

+0.342 (+0.99%)

10/13/21 UBS
Siemens Healthineers price target raised to EUR 54 from EUR 48 at UBS
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold at Societe Generale
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold from Buy at Societe Generale
09/10/21 Barclays
Siemens Healthineers price target raised to EUR 55 from EUR 49 at Barclays
SYK Stryker
$273.17 /

-2.71 (-0.98%)

09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 SVB Leerink
Stryker price target raised to $300 from $290 at SVB Leerink
TDY Teledyne
$444.97 /

-1.14 (-0.26%)

07/30/21 Cowen
Teledyne price target raised to $525 from $500 at Cowen
06/08/21 Goldman Sachs
Teledyne reinstated with a Neutral at Goldman Sachs
05/25/21 BofA
Teledyne initiated with a Buy at BofA
04/29/21 Needham
Teledyne price target raised to $500 from $416 at Needham
VRAY ViewRay
$7.01 /

+0.205 (+3.01%)

10/19/21 Piper Sandler
ViewRay strength attributed to MIRAGE study recruiting halt, says Piper Sandler
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
06/25/21 Morgan Stanley
ViewRay upgraded to Equal Weight from Underweight at Morgan Stanley
VREX Varex Imaging
$27.05 /

+0.12 (+0.45%)

02/05/21 Oppenheimer
Varex Imaging upgraded to Outperform from Perform at Oppenheimer
VREX Varex Imaging
$27.05 /

+0.12 (+0.45%)

VRAY ViewRay
$7.01 /

+0.205 (+3.01%)

TDY Teledyne
$444.97 /

-1.14 (-0.26%)

SYK Stryker
$273.17 /

-2.71 (-0.98%)

SNY Sanofi
$49.85 /

+ (+0.00%)

SGEN Seagen
$175.45 /

+4.14 (+2.42%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

PHG Philips
$47.81 /

-0.3 (-0.62%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

NVCR Novocure
$119.37 /

-1.5 (-1.24%)

NTRA Natera
$115.78 /

+0.82 (+0.71%)

NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

NBTX Nanobiotix
$12.35 /

-0.7 (-5.36%)

MYGN Myriad Genetics
$32.47 /

+0.03 (+0.09%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

BIOC Biocept
$3.84 /

-0.02 (-0.52%)

BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

ARAY Accuray
$4.39 /

+0.02 (+0.46%)

  • 22
    Jul
  • 11
    Feb
  • 22
    Jan
  • 05
    Jan
  • 11
    Dec
SNY Sanofi
$49.85 /

+ (+0.00%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

PHG Philips
$47.81 /

-0.3 (-0.62%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

HTHIY Hitachi
$119.48 /

+1.76 (+1.50%)

DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

VREX Varex Imaging
$27.05 /

+0.12 (+0.45%)

SYK Stryker
$273.17 /

-2.71 (-0.98%)

SNY Sanofi
$49.85 /

+ (+0.00%)

SMMNY Siemens Healthineers
$34.73 /

+0.342 (+0.99%)

SGEN Seagen
$175.45 /

+4.14 (+2.42%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

PHG Philips
$47.81 /

-0.3 (-0.62%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

NVCR Novocure
$119.37 /

-1.5 (-1.24%)

NTRA Natera
$115.78 /

+0.82 (+0.71%)

NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

MYGN Myriad Genetics
$32.47 /

+0.03 (+0.09%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

TDY Teledyne
$444.97 /

-1.14 (-0.26%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

Monday
Recommendations
Medtronic exit from Aziyo Biologics deal not unexpected, says Piper Sandler » 19:47
10/25/21
10/25
19:47
10/25/21
19:47
AZYO

Aziyo Biologics

$5.30 /

-0.23 (-4.16%)

, MDT

Medtronic

$123.60 /

+0.51 (+0.41%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien keeps his Overweight rating and $14 price target on Aziyo Biologics (AZYO) after the company earlier announced that its partner Medtronic (MDT) had ceased the distribution of Cellular Bone Matrix products, terminating their agreement. The decision comes after Aziyo's June recall of the product and likely does not come as a major surprise to investors, the analyst tells investors in a research note. The company's preannounced in-line Q3 revenues were also "encouraging" as many medtech companies have posted choppy third quarters due to the impact of COVID-19, O'Brien adds.

ShowHide Related Items >><<
MDT Medtronic
$123.60 /

+0.51 (+0.41%)

AZYO Aziyo Biologics
$5.30 /

-0.23 (-4.16%)

AZYO Aziyo Biologics
$5.30 /

-0.23 (-4.16%)

06/10/21 Truist
Aziyo Biologics price target lowered to $16 from $20 at Truist
06/07/21 Piper Sandler
Piper cuts Aziyo target but sees Medtronic sticking with company
05/05/21 Piper Sandler
Piper Sandler 'strongly' encourages investors buy Aziyo Biologics
11/19/20 Piper Sandler
Aziyo Biologics posted 'nice revenue beat' in Q3, says Piper Sandler
MDT Medtronic
$123.60 /

+0.51 (+0.41%)

10/18/21 Piper Sandler
Medtronic deal would not address 'Achilles' heel' of platform, say Piper
10/18/21 Stifel
Stifel 'cautiously positive' on Medtronic despite 'disappointing' ON-MED update
10/18/21 Morgan Stanley
Medtronic bias positive at Morgan Stanley despite 'not optimal' ON MED update
10/18/21 Wells Fargo
Medtronic price target lowered to $144 from $151 at Wells Fargo
MDT Medtronic
$123.60 /

+0.51 (+0.41%)

AZYO Aziyo Biologics
$5.30 /

-0.23 (-4.16%)

MDT Medtronic
$123.60 /

+0.51 (+0.41%)

MDT Medtronic
$123.60 /

+0.51 (+0.41%)

MDT Medtronic
$123.60 /

+0.51 (+0.41%)

Hot Stocks
Medtronic informs Aziyo of decision to cease distribution of CBM products » 16:05
10/25/21
10/25
16:05
10/25/21
16:05
AZYO

Aziyo Biologics

$5.33 /

-0.2 (-3.62%)

, MDT

Medtronic

$123.31 /

+0.22 (+0.18%)

Aziyo Biologics (AZYO)…

Aziyo Biologics (AZYO) announced that it was informed by Medtronic (MDT) that, after conducting a thorough review of customer and patient needs, Medtronic has made the decision to cease distribution of Cellular Bone Matrix, or CBM, products. As a result of this decision, the two companies are working toward a mutual termination of their FiberCel distribution agreement.

ShowHide Related Items >><<
MDT Medtronic
$123.31 /

+0.22 (+0.18%)

AZYO Aziyo Biologics
$5.33 /

-0.2 (-3.62%)

AZYO Aziyo Biologics
$5.33 /

-0.2 (-3.62%)

06/10/21 Truist
Aziyo Biologics price target lowered to $16 from $20 at Truist
06/07/21 Piper Sandler
Piper cuts Aziyo target but sees Medtronic sticking with company
05/05/21 Piper Sandler
Piper Sandler 'strongly' encourages investors buy Aziyo Biologics
11/19/20 Piper Sandler
Aziyo Biologics posted 'nice revenue beat' in Q3, says Piper Sandler
MDT Medtronic
$123.31 /

+0.22 (+0.18%)

10/18/21 Piper Sandler
Medtronic deal would not address 'Achilles' heel' of platform, say Piper
10/18/21 Stifel
Stifel 'cautiously positive' on Medtronic despite 'disappointing' ON-MED update
10/18/21 Morgan Stanley
Medtronic bias positive at Morgan Stanley despite 'not optimal' ON MED update
10/18/21 Wells Fargo
Medtronic price target lowered to $144 from $151 at Wells Fargo
MDT Medtronic
$123.31 /

+0.22 (+0.18%)

AZYO Aziyo Biologics
$5.33 /

-0.2 (-3.62%)

MDT Medtronic
$123.31 /

+0.22 (+0.18%)

MDT Medtronic
$123.31 /

+0.22 (+0.18%)

MDT Medtronic
$123.31 /

+0.22 (+0.18%)

Conference/Events
American Society for Radiation Oncology to hold annual meeting » 08:46
10/25/21
10/25
08:46
10/25/21
08:46
ARAY

Accuray

$4.37 /

+0.3 (+7.37%)

, NVS

Novartis

$84.88 /

+0.2 (+0.24%)

, AZN

AstraZeneca

$61.81 /

+0.62 (+1.01%)

, BAYRY

Bayer

$14.13 /

+0.04 (+0.28%)

, BD

Budget Group

/

+

, BIOC

Biocept

$3.85 /

-0.09 (-2.28%)

, BSX

Boston Scientific

$44.85 /

-0.045 (-0.10%)

, BMY

Bristol-Myers

$57.59 /

-0.225 (-0.39%)

, EKTAY

Elekta

$11.63 /

+0.29 (+2.56%)

, GRTX

Galera Therapeutics

$1.83 /

-0.185 (-9.20%)

, DNA

Ginkgo Bioworks

$13.13 /

-0.08 (-0.61%)

, HTHIY

Hitachi

$117.72 /

+0.79 (+0.68%)

, MRK

Merck

$81.16 /

-0.01 (-0.01%)

, MYGN

Myriad Genetics

$32.49 /

-0.005 (-0.02%)

, NBTX

Nanobiotix

$13.05 /

+ (+0.00%)

, NNOX

Nano-X Imaging

$22.72 /

-1.01 (-4.26%)

, NTRA

Natera

$114.98 /

+2.56 (+2.28%)

, NVCR

Novocure

$120.88 /

-1.28 (-1.05%)

, PHG

Philips

$48.11 /

+0.6 (+1.26%)

, REGN

Regeneron

$572.62 /

+3.73 (+0.66%)

, SNY

Sanofi

$49.87 /

+0.67 (+1.36%)

, SGEN

Seagen

$171.55 /

-2.33 (-1.34%)

, SMMNY

Siemens Healthineers

$34.39 /

+0.238 (+0.70%)

, SYK

Stryker

$275.78 /

-0.69 (-0.25%)

, TDY

Teledyne

$446.11 /

+2.415 (+0.54%)

, VRAY

ViewRay

$6.81 /

+0.075 (+1.11%)

, VREX

Varex Imaging

$26.93 /

+0.15 (+0.56%)

63rd Annual ASTRO Meeting…

63rd Annual ASTRO Meeting 2021 will be held in Chicago on October 24-27.Webcast Link

ShowHide Related Items >><<
VRAY ViewRay
$6.81 /

+0.075 (+1.11%)

TDY Teledyne
$446.11 /

+2.415 (+0.54%)

SYK Stryker
$275.78 /

-0.69 (-0.25%)

SNY Sanofi
$49.87 /

+0.67 (+1.36%)

SMMNY Siemens Healthineers
$34.39 /

+0.238 (+0.70%)

SGEN Seagen
$171.55 /

-2.33 (-1.34%)

REGN Regeneron
$572.62 /

+3.73 (+0.66%)

PHG Philips
$48.11 /

+0.6 (+1.26%)

NVS Novartis
$84.88 /

+0.2 (+0.24%)

NVCR Novocure
$120.88 /

-1.28 (-1.05%)

NTRA Natera
$114.98 /

+2.56 (+2.28%)

NNOX Nano-X Imaging
$22.72 /

-1.01 (-4.26%)

NBTX Nanobiotix
$13.05 /

+ (+0.00%)

MYGN Myriad Genetics
$32.49 /

-0.005 (-0.02%)

MRK Merck
$81.16 /

-0.01 (-0.01%)

HTHIY Hitachi
$117.72 /

+0.79 (+0.68%)

GRTX Galera Therapeutics
$1.83 /

-0.185 (-9.20%)

EKTAY Elekta
$11.63 /

+0.29 (+2.56%)

DNA Ginkgo Bioworks
$13.13 /

-0.08 (-0.61%)

BSX Boston Scientific
$44.85 /

-0.045 (-0.10%)

BMY Bristol-Myers
$57.59 /

-0.225 (-0.39%)

BIOC Biocept
$3.85 /

-0.09 (-2.28%)

BAYRY Bayer
$14.13 /

+0.04 (+0.28%)

AZN AstraZeneca
$61.81 /

+0.62 (+1.01%)

ARAY Accuray
$4.37 /

+0.3 (+7.37%)

ARAY Accuray
$4.37 /

+0.3 (+7.37%)

01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
NVS Novartis
$84.88 /

+0.2 (+0.24%)

10/12/21 Berenberg
Novartis price target lowered to CHF 88 from CHF 96 at Berenberg
10/08/21 UBS
Novartis price target lowered to CHF 92 from CHF 95 at UBS
09/29/21 Stifel
Blueprint Medicines rersumed with a Hold at Stifel
09/20/21 Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
AZN AstraZeneca
$61.81 /

+0.62 (+1.01%)

10/19/21 UBS
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS
10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
BAYRY Bayer
$14.13 /

+0.04 (+0.28%)

10/21/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
08/09/21 Berenberg
Bayer price target lowered to EUR 60 from EUR 74 at Berenberg
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
BD Budget Group
/

+

BIOC Biocept
$3.85 /

-0.09 (-2.28%)

10/08/21 Brookline
Biocept assumed with a Buy at Brookline
BSX Boston Scientific
$44.85 /

-0.045 (-0.10%)

10/06/21 Piper Sandler
Boston Scientific acquisition of Baylis looks 'solid,' says Piper Sandler
09/22/21 Piper Sandler
Boston Scientific said unlikely to hit low end of Q3 sales outlook, notes Piper
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
BMY Bristol-Myers
$57.59 /

-0.225 (-0.39%)

10/25/21 Citi
Bristol-Myers report of Aurinia approach 'looks credible,' says Citi
10/12/21 Morgan Stanley
Bristol-Myers price target lowered to $66 from $71 at Morgan Stanley
10/08/21 Morgan Stanley
Bristol-Myers' UC trial miss an incremental negative, says Morgan Stanley
10/08/21 Barclays
Bristol-Myers price target lowered to $68 from $71 at Barclays
EKTAY Elekta
$11.63 /

+0.29 (+2.56%)

08/27/21 JPMorgan
Elekta price target raised to SEK 95 from SEK 91 at JPMorgan
06/02/21 JPMorgan
Elekta price target raised to SEK 91 from SEK 82 at JPMorgan
04/27/21 JPMorgan
Elekta price target raised to SEK 82 from SEK 80 at JPMorgan
03/18/21 JPMorgan
Elekta downgraded to Underweight from Neutral at JPMorgan
GRTX Galera Therapeutics
$1.83 /

-0.185 (-9.20%)

10/21/21 Citi
Galera Therapeutics price target lowered to $11 from $21 at Citi
10/20/21 H.C. Wainwright
Galera Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/19/21 BofA
Galera double downgraded to Underperform at BofA after ROMAN trial miss
10/19/21 BofA
Galera Therapeutics downgraded to Underperform from Buy at BofA
DNA Ginkgo Bioworks
$13.13 /

-0.08 (-0.61%)

10/20/21 Raymond James
Raymond James expects more equity-based payments for Ginkgo as milestones met
10/13/21 Raymond James
Ginkgo Bioworks initiated with an Outperform at Raymond James
10/12/21 William Blair
Blair starts Ginkgo at Outperform on 'significant' competitive advantage
10/12/21 William Blair
Ginkgo Bioworks initiated with an Outperform at William Blair
HTHIY Hitachi
$117.72 /

+0.79 (+0.68%)

11/20/20 Goldman Sachs
Hitachi reinstated with a Sell at Goldman Sachs
MRK Merck
$81.16 /

-0.01 (-0.01%)

10/22/21 SVB Leerink
Merck price target raised to $105 from $104 at SVB Leerink
10/19/21 Roth Capital
Enanta drug 'naturally more potent' than Merck's antiviral, says Roth Capital
10/19/21 Evercore ISI
Atea's Phase 2 design disappoints, but drug has not failed, says Evercore ISI
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
MYGN Myriad Genetics
$32.49 /

-0.005 (-0.02%)

10/14/21 Cowen
Myriad Genetics coverage transferred at Cowen
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Myriad Genetics initiated with a Market Perform at Raymond James
06/03/21 Goldman Sachs
Myriad Genetics initiated with a Sell at Goldman Sachs
NBTX Nanobiotix
$13.05 /

+ (+0.00%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
NNOX Nano-X Imaging
$22.72 /

-1.01 (-4.26%)

04/19/21 Ladenburg
Ladenburg starts Nano-X Imaging at Buy with $52 price target
04/19/21 Ladenburg
Nano-X Imaging initiated with a Buy at Ladenburg
02/01/21 Cantor Fitzgerald
Cantor Fitzgerald reiterates Overweight on Nano-X Imaging, lowers target to $67
NTRA Natera
$114.98 /

+2.56 (+2.28%)

10/19/21 Canaccord
Natera Prospera Lung launch to continue momentum, says Canaccord
10/14/21 Cowen
Natera coverage transferred at Cowen
08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
08/09/21 Piper Sandler
Natera price target raised to $160 from $155 at Piper Sandler
NVCR Novocure
$120.88 /

-1.28 (-1.05%)

10/25/21 Piper Sandler
Novocure price target lowered to $195 from $235 at Piper Sandler
09/21/21 Piper Sandler
Novocure clinical update should come in next few weeks, says Piper Sandler
07/30/21 Mizuho
Novocure price target lowered to $200 from $229 at Mizuho
PHG Philips
$48.11 /

+0.6 (+1.26%)

10/19/21 JPMorgan
Philips price target lowered to EUR 36.40 from EUR 40.90 at JPMorgan
10/19/21 Deutsche Bank
Philips price target lowered to EUR 42 from EUR 43 at Deutsche Bank
09/10/21 Barclays
Philips price target lowered to EUR 53 from EUR 54 at Barclays
09/08/21
Fly Intel: Top five analyst initiations
REGN Regeneron
$572.62 /

+3.73 (+0.66%)

10/22/21 H.C. Wainwright
Regeneron price target raised to $842 from $831 at H.C. Wainwright
10/14/21 H.C. Wainwright
H.C. Wainwright 'enthusiastic' on Regeneron, sees no barrier for REGEN-COV nod
10/04/21 Piper Sandler
Amgen's AMG 451 looks competitive with Dupixent, says Piper Sandler
10/04/21 H.C. Wainwright
Regeneron selloff brings 'excellent entry point,' says H.C. Wainwright
SNY Sanofi
$49.87 /

+0.67 (+1.36%)

10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
SGEN Seagen
$171.55 /

-2.33 (-1.34%)

10/14/21 BTIG
Seagen assumed with a Neutral at BTIG
09/27/21 RBC Capital
Seagen price target raised to $154 from $148 at RBC Capital
05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
SMMNY Siemens Healthineers
$34.39 /

+0.238 (+0.70%)

10/13/21 UBS
Siemens Healthineers price target raised to EUR 54 from EUR 48 at UBS
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold at Societe Generale
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold from Buy at Societe Generale
09/10/21 Barclays
Siemens Healthineers price target raised to EUR 55 from EUR 49 at Barclays
SYK Stryker
$275.78 /

-0.69 (-0.25%)

09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 SVB Leerink
Stryker price target raised to $300 from $290 at SVB Leerink
TDY Teledyne
$446.11 /

+2.415 (+0.54%)

07/30/21 Cowen
Teledyne price target raised to $525 from $500 at Cowen
06/08/21 Goldman Sachs
Teledyne reinstated with a Neutral at Goldman Sachs
05/25/21 BofA
Teledyne initiated with a Buy at BofA
04/29/21 Needham
Teledyne price target raised to $500 from $416 at Needham
VRAY ViewRay
$6.81 /

+0.075 (+1.11%)

10/19/21 Piper Sandler
ViewRay strength attributed to MIRAGE study recruiting halt, says Piper Sandler
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
06/25/21 Morgan Stanley
ViewRay upgraded to Equal Weight from Underweight at Morgan Stanley
VREX Varex Imaging
$26.93 /

+0.15 (+0.56%)

02/05/21 Oppenheimer
Varex Imaging upgraded to Outperform from Perform at Oppenheimer
VREX Varex Imaging
$26.93 /

+0.15 (+0.56%)

VRAY ViewRay
$6.81 /

+0.075 (+1.11%)

TDY Teledyne
$446.11 /

+2.415 (+0.54%)

SYK Stryker
$275.78 /

-0.69 (-0.25%)

SNY Sanofi
$49.87 /

+0.67 (+1.36%)

SGEN Seagen
$171.55 /

-2.33 (-1.34%)

REGN Regeneron
$572.62 /

+3.73 (+0.66%)

PHG Philips
$48.11 /

+0.6 (+1.26%)

NVS Novartis
$84.88 /

+0.2 (+0.24%)

NVCR Novocure
$120.88 /

-1.28 (-1.05%)

NTRA Natera
$114.98 /

+2.56 (+2.28%)

NNOX Nano-X Imaging
$22.72 /

-1.01 (-4.26%)

NBTX Nanobiotix
$13.05 /

+ (+0.00%)

MYGN Myriad Genetics
$32.49 /

-0.005 (-0.02%)

MRK Merck
$81.16 /

-0.01 (-0.01%)

GRTX Galera Therapeutics
$1.83 /

-0.185 (-9.20%)

BSX Boston Scientific
$44.85 /

-0.045 (-0.10%)

BMY Bristol-Myers
$57.59 /

-0.225 (-0.39%)

BIOC Biocept
$3.85 /

-0.09 (-2.28%)

BAYRY Bayer
$14.13 /

+0.04 (+0.28%)

AZN AstraZeneca
$61.81 /

+0.62 (+1.01%)

ARAY Accuray
$4.37 /

+0.3 (+7.37%)

  • 22
    Jul
  • 11
    Feb
  • 22
    Jan
  • 05
    Jan
  • 11
    Dec
SNY Sanofi
$49.87 /

+0.67 (+1.36%)

REGN Regeneron
$572.62 /

+3.73 (+0.66%)

PHG Philips
$48.11 /

+0.6 (+1.26%)

NVS Novartis
$84.88 /

+0.2 (+0.24%)

MRK Merck
$81.16 /

-0.01 (-0.01%)

HTHIY Hitachi
$117.72 /

+0.79 (+0.68%)

DNA Ginkgo Bioworks
$13.13 /

-0.08 (-0.61%)

BSX Boston Scientific
$44.85 /

-0.045 (-0.10%)

BMY Bristol-Myers
$57.59 /

-0.225 (-0.39%)

BAYRY Bayer
$14.13 /

+0.04 (+0.28%)

AZN AstraZeneca
$61.81 /

+0.62 (+1.01%)

VREX Varex Imaging
$26.93 /

+0.15 (+0.56%)

SYK Stryker
$275.78 /

-0.69 (-0.25%)

SNY Sanofi
$49.87 /

+0.67 (+1.36%)

SMMNY Siemens Healthineers
$34.39 /

+0.238 (+0.70%)

SGEN Seagen
$171.55 /

-2.33 (-1.34%)

REGN Regeneron
$572.62 /

+3.73 (+0.66%)

PHG Philips
$48.11 /

+0.6 (+1.26%)

NVS Novartis
$84.88 /

+0.2 (+0.24%)

NVCR Novocure
$120.88 /

-1.28 (-1.05%)

NTRA Natera
$114.98 /

+2.56 (+2.28%)

NNOX Nano-X Imaging
$22.72 /

-1.01 (-4.26%)

MYGN Myriad Genetics
$32.49 /

-0.005 (-0.02%)

MRK Merck
$81.16 /

-0.01 (-0.01%)

GRTX Galera Therapeutics
$1.83 /

-0.185 (-9.20%)

DNA Ginkgo Bioworks
$13.13 /

-0.08 (-0.61%)

BSX Boston Scientific
$44.85 /

-0.045 (-0.10%)

BMY Bristol-Myers
$57.59 /

-0.225 (-0.39%)

BAYRY Bayer
$14.13 /

+0.04 (+0.28%)

AZN AstraZeneca
$61.81 /

+0.62 (+1.01%)

TDY Teledyne
$446.11 /

+2.415 (+0.54%)

REGN Regeneron
$572.62 /

+3.73 (+0.66%)

NVS Novartis
$84.88 /

+0.2 (+0.24%)

NNOX Nano-X Imaging
$22.72 /

-1.01 (-4.26%)

MRK Merck
$81.16 /

-0.01 (-0.01%)

GRTX Galera Therapeutics
$1.83 /

-0.185 (-9.20%)

DNA Ginkgo Bioworks
$13.13 /

-0.08 (-0.61%)

BSX Boston Scientific
$44.85 /

-0.045 (-0.10%)

BMY Bristol-Myers
$57.59 /

-0.225 (-0.39%)

AZN AstraZeneca
$61.81 /

+0.62 (+1.01%)

Friday
Periodicals
Judge says J&J talc litigation can proceed for now, Bloomberg says » 17:30
10/22/21
10/22
17:30
10/22/21
17:30
JNJ

Johnson & Johnson

$163.71 /

+0.39 (+0.24%)

Johnson & Johnson has…

Johnson & Johnson has lost the first round in a bankruptcy lawsuit over talc-based powder claims, according to Bloomberg.

ShowHide Related Items >><<
JNJ Johnson & Johnson
$163.71 /

+0.39 (+0.24%)

JNJ Johnson & Johnson
$163.71 /

+0.39 (+0.24%)

10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
10/20/21 Baird
Intuitive Surgical price target raised to $370 from $350 at Baird
10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
10/04/21 Piper Sandler
Xencor price target raised to $75 from $63 at Piper Sandler
JNJ Johnson & Johnson
$163.71 /

+0.39 (+0.24%)

JNJ Johnson & Johnson
$163.71 /

+0.39 (+0.24%)

JNJ Johnson & Johnson
$163.71 /

+0.39 (+0.24%)

JNJ Johnson & Johnson
$163.71 /

+0.39 (+0.24%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.